spacer
home > pmps > winter 2017 > made of glass
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Made of Glass

PMPS: At Gerresheimer, you offer different types of glass. Do any prove more popular for particular products and, if so, why?

Jens Heymann: Our customers require the highest quality glass primary packaging for their pharmaceuticals. Many products are packaged in glass – for example, those that use glass vials include vaccines, analgesics, sedatives and insulin preparations for injection. Glass is a highly favoured material, because it is hard, transparent, has excellent barrier properties and is inert, so it does not interact with the active ingredients. Hydrolysis resistant type 1 borosilicate glass is used as packaging for dissolved and lyophilised preparations, for instance.

Our entire range of pharmaceutical packaging is available in flint or amber glass, and we also make moulded high-quality special primary packaging such as vials and cartridges from borosilicate glass tubing.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Having joined Gerresheimer in 2014, Jens Heymann has since been their Global Vice President of Finance and Controlling, and became Senior Vice President of Europe and Asia at Tubular Glass. He came to the company from the Rexam Group, where he held various positions up to Director of Group Financial Planning and Analysis since 2003.
spacer
Jens Heymann
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ADM Supports Clinical Trial into Effects of Probiotic Supplements for COVID-19 Patients in Hospital Care

ADM and Hospital de Sagunto, one of the largest medical centers in the Valencia region, today announce their partnership for a clinical trial into the effects of using a food supplement containing live microbial strains to promote gut microbiome balance and help improve health functions related to outcomes for COVID-19 patients in high-risk groups. On 18th March Dr Xavier Cortés, gastroenterologist at Hospital de Sagunto, communicated with medical staff in China who had observed that many COVID-19 patients had exhibited abnormal changes in their gut microbiome.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement